Adaptive Biotechnologies Corp at Cowen HealthCare Conference Transcript
All right. Good morning, everybody. It's our pleasure to welcome Chad Robins from Adaptive Biotechnologies to the Cowen Conference. Thanks for being here, Chad. Adaptive's immune profiling platform is well-validated and its product pipeline continues to advance. Chad and his team have successfully demonstrated their regulatory and reimbursement prowess via clonoSEQ and also via many clonoSEQ and immunoSEQ-related partnerships. Over the next 30 minutes or so, we're going to focus on the outlook for 2020, progress across the base business as well as pipeline developments and the associated time lines. So again, thanks, Chad, for joining us.
Thanks for having me here, Doug.
Questions & Answers
I wanted to spend a few minutes just going back to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
